Current controlled trials in cardiovascular medicine / / BioMed Central, PubMed Central.
Saved in:
| : | |
|---|---|
| TeilnehmendeR: | |
| Place / Publishing House: | London : : BioMed Central,, [2000] |
| Publication history: | Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005). |
| Language: | English |
| Physical Description: | 1 online resource |
| Notes: |
|
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
- Comments on ALLHAT and doxazosin
- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
- Debate: PCI vs CABG: a moving target, but we are gaining
- Debate: Should statin be used in patients with heart failure?
- Debate: Statins should be used in patients with heart failure
- Cytokines as new treatment targets in chronic heart failure
- Therapeutic angiogenesis for cardiovascular disease
- Distal protection devices during percutaneous coronary and carotid interventions
- Biventricular pacing in heart failure: update on results from clinical trials
- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
- A new era in hypertension research: discussing the findings of ALLHAT.